Brokers' take: Phillip upgrades and raises TP on Manulife US Reit

Published Wed, Feb 16, 2022 · 04:39 PM

PHILLIP Securities upgraded its call on Manulife US Real Estate Investment Trust BTOU : BTOU 0%(Reit) to "buy" from "accumulate" and raised its target price to US$0.86 from US$0.84 previously.

This comes despite lower-than-expected portfolio occupancy rates in FY2021 which led to a lower DPU of 5.33 US cents, below Phillip's forecast.

With the occupancy lower than anticipated, Phillip lowered expected DPU for FY2022 to FY2024 by 2.1 to 6.3 per cent to factor in the gradual recovery, it stated in a research report on Wednesday (Feb 16).

However, its analyst Natalie Ong noted that the US office market appears to be at an inflection point, which shows recovery in leasing momentum.

She expects DPU to grow to higher levels in the long term and that attributed the change in target price to the expected recovery of the market.

Manulife US Reit reported physical occupancy rates of 25 to 30 per cent and said it provided rental abatement of US$2.4 million in FY2021. Ong said she projects the more pronounced return-to-office to lift carpark income and lower rental abatement burden in the upcoming years.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

The analyst also highlighted that the US office market shows signs of recovery through the improving net effective rents, longer lease tenures signed, decline in subleasing and improving rental growth outlook for Manulife US Reit cities. She said FY2022 renewals could yield positive reversions.

Units of Manulife US Reit were trading at S$0.66, down 0.8 per cent or S$0.005 as at 4.28 pm on Wednesday.

READ MORE:

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here